In October 2025, Air Water Inc., a Japanese industrial gas and chemicals company listed on the Tokyo Stock Exchange, disclosed that it had found inappropriate accounting treatment involving the deferral of loss recognition. A special investigation committee was established. The committee's final report, released on 3 April 2026, revealed systemic misconduct across multiple subsidiaries spanning several years.
The investigation found fictitious inventory, inflated sales, premature revenue recognition, deferred expenses and the use of unnecessary intermediaries — all driven by a top-down culture of excessive performance pressure from senior management. The misconduct involved a cumulative overstatement of approximately ¥24 billion in revenue and ¥5.9 billion in operating profit through September 2025.
Air Water's board responded by appointing an independent outside director as board chair, creating a chief accounting and finance officer role, and imposing compensation clawbacks: the president and representative director voluntarily returned 100% of monthly compensation for three months, while other directors and executive officers took 20% to 50% salary reductions.
Air Water's subsidiaries booked fictitious inventory and inflated sales, overstating revenue by ¥24 billion until a special investigation found the rot.
A top-down culture of excessive performance pressure created incentives to fabricate revenue rather than accept lower results.
Internal controls across the group were weak enough that multiple subsidiaries could engage in the same type of misconduct simultaneously without detection.
The company waited until a special investigation committee confirmed the scale before taking meaningful action, meaning the inflated figures affected investor decisions for years.
When a company demands results that honest accounting cannot deliver, the books will be made to fit — and the subsidiaries that fake them are rarely acting alone.
Air Water replaced its board chair with an independent outside director, created a new chief accounting and finance officer role, and imposed compensation clawbacks on the president and other executives. The company published a recurrence prevention plan.
FOLLOW THE EVIDENCE